✦ LIBER ✦

Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3-Year Randomized Placebo-Controlled Clinical Trial With a 2-Year Open Extension

✍ Scribed by Caroline Brumsen; Socrates E. Papapoulos; Paul Lips; Petronella H. L. M. Geelhoed-Duijvestijn; Neveen A. T. Hamdy; Jan Otto Landman; Eugene V. Mccloskey; J. Coen Netelenbos; Ernest K. J. Pauwels; Jan C. Roos; Rob M. Valentijn; Aeilko H. Zwinderman

Book ID: 111487122
Publisher: American Society for Bone and Mineral Research
Year: 2002
Tongue: English
Weight: 108 KB
Volume: 17
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.2002.17.6.1057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of bazedoxifene

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

✍ T. J. de Villiers; A. A. Chines; S. Palacios; P. Lips; A. Z. Sawicki; A. B. Levi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 269 KB

Safety and tolerability of bazedoxifene

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: Results of A 5-year, randomized, placebo-controlled phase 3 trial

✍ T.J. de Villiers; D.L. Kendler; A.A. Chines; P. Lips; J.M. Kaufman; A.B. Levine; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Safety and Tolerability of Bazedoxifene

Safety and Tolerability of Bazedoxifene in Postmenopausal Women With Osteoporosis: Results of a 5-year, Randomized, Placebo-controlled Phase 3 Trial

✍ T. de Villiers; D. Kendler; A. Chines; P. Lips; J. Kaufman; A. Levine; N. Mairon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Two Years of Denosumab and Teriparatide

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

✍ Leder, Benjamin Z.; Tsai, Joy N.; Uihlein, Alexander V.; Burnett-Bowie, Sherri-A 📂 Article 📅 2014 🏛 Endocrine Society 🌐 English ⚖ 611 KB

Quality of life in children with osteoge

Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial

✍ Dieke H. J. Kok; Ralph J. B. Sakkers; Arieke J. Janse; Hans E. H. Pruijs; Ab J. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 136 KB

Effects of Oral Alendronate on BMD in Ad

Effects of Oral Alendronate on BMD in Adult Patients With Osteogenesis Imperfecta: A 3-Year Randomized Placebo-Controlled Trial

✍ Guillaume Chevrel; Anne-Marie Schott; Elisabeth Fontanges; Jeanne E Charrin; Gen 📂 Article 📅 2005 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 116 KB